KNSA KINIKSA PHARMACEUTICALS INTERNATIONAL PLC Business Restructuring 8-K Filing 2025 - Management Changes On June 3, 2025, Kiniksa Pharmaceuticals held its Annual Meeting of Shareholders, where proposals for director re-elections and auditing firm appointments were overwhelmingly approved by shareholders, alongside plans to enhance capital structure with shares worth approximately $6,976.33.Get access to all SEC 8-K filings of the KINIKSA PHARMACEUTICALS INTERNATIONAL PLC